Welcome

Welcome to the Investor Relations section of Vitruvia. This area is dedicated to keeping shareholders and potential investors up to date with relevant information on Vitruvia and its shares.

Press releases


Vitruvia Medical AG reports first-half 2021 results in line with expectations. Board of Directors confirms full-year and 2022 forecasts

Anglikon, September 13, 2021 Vitruvia Medical AG is right on target after the first six months of…

Vitruvia Medical’s first Circular Clinic Supply Center for robotic instruments goes live with first customers

Vitruvia is the first European service provider to specialize in circular systems for highly…

AI-controlled cleaning systems for surgical robots

The use of medical products and technology in operating theaters is highly resource-intensive and…

More Press releases

Ad-hoc News


Vitruvia Medical AG: Listing on Munich Stock Exchange

Effective today, the shares of Vitruvia Medical AG are trading on the Munich Stock Exchange.

Key performance indicatorsVitruvia Medical AG share

NameWerte
WKNA2PDWF
ISINCH0461931419
ValorCH046193141
Number of sharesThe share capital is CHF 1,827,757.00 and is divided into 1,827,757 registered shares, each with a nominal value of CHF 1.00.
Availability of sharesAll registered shares are freely transferable.
End of fiscal yearDecember 31
Stock exchangeMunich Stock Exchange
Market segmentGeneral open market
Initial listingMay 11, 2021

Course data

NameWerte
Current share price (Link to Munich Stock Exchange)
52-Week-HighEUR 22,60
52-Week-LowEUR 11,00

Dates

Sep 27, 2021 | Extraordinary General Assembly
Vitruvia Medical AG
Sep 19, 2021 | Publication of half-year financial statements as of June 30, 2021 Vitruvia Medical AG (Group)
Sep 19, 2021 | Publication of half-year report as of
June 30, 2021 Vitruvia Medical AG (Group)
Mar 31, 2021  |  Annual General Assembly
Feb 28, 2021  |  Publication of annual financial statements

Management Transactions

July 2, 2021 | Director's Dealing Vitruvia Medical AGJuly 2, 2021 | Director's Dealing Vitruvia Medical AGMay 27, 2021 | Director's Dealing Vitruvia Medical AGMay 25, 2021 | Director's Dealing Vitruvia Medical AGMay 21, 2021 | Director's Dealing Vitruvia Medical AG

Your contact

Markus A. Bertschin
President of the Board of Directors

T +41 (0)44 915 33 78
M +41 (0)79 233 26 09
bertschin@vitruvia-med.com

Vitruvia Medical AG
Kesselackerstrasse 18
5611 Anglikon I Switzerland

Torsten Cejka
Board of Directors

T +41 (0)44 915 33 78
M +49 (0) 173 887 18 11
cejka@vitruvia-med.com

Vitruvia Medical AG
Margaretenstr. 14
39218 Schönebeck (Elbe) I Germany